Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Veronique Monnaert"'
Autor:
Roméo Cecchelli, Eric Monflier, Veronique Monnaert, Laurence Fenart, Didier Betbeder, Christophe Landry, Sébastien Tilloy, Anne-Marie Lenfant, Hervé Bricout
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 311:1115-1120
Association between doxorubicin (DOX) and gamma-cyclodextrin (gamma-CD) or hydroxypropyl-gamma-CD (HP-gamma-CD) has been examined to increase the delivery of this antitumoral agent to the brain. The stoichiometry and the stability constant of gamma-C
Autor:
Roméo Cecchelli, Hervé Bricout, Sébastien Tilloy, Veronique Monnaert, Eric Monflier, Laurence Fenart
Publikováno v:
Bioorganic and Medicinal Chemistry Letters
Bioorganic and Medicinal Chemistry Letters, 2006, 16, p. 2154-2157
Bioorganic and Medicinal Chemistry Letters, Elsevier, 2006, 16, p. 2154-2157
Bioorganic and Medicinal Chemistry Letters, 2006, 16, p. 2154-2157
Bioorganic and Medicinal Chemistry Letters, Elsevier, 2006, 16, p. 2154-2157
International audience; Co-incubations of various β-cyclodextrins and doxorubicin have been evaluated on an in vitro model of blood-brain barrier in order to increase the delivery of this P-gp substrate to the brain. Among these cyclodextrins used,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b7933a8dd3f99007fc07854aedab797
https://hal-univ-artois.archives-ouvertes.fr/hal-00543357
https://hal-univ-artois.archives-ouvertes.fr/hal-00543357
Autor:
Hervé Bricout, Sébastien Tilloy, Veronique Monnaert, Eric Monflier, Laurence Fenart, Roméo Cecchelli
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics
Journal of Pharmacology and Experimental Therapeutics, American Society for Pharmacology and Experimental Therapeutics, 2004, 310 (2), p. 745-751
Journal of Pharmacology and Experimental Therapeutics, 2004, 310 (2), p. 745-751
Journal of Pharmacology and Experimental Therapeutics, American Society for Pharmacology and Experimental Therapeutics, 2004, 310 (2), p. 745-751
Journal of Pharmacology and Experimental Therapeutics, 2004, 310 (2), p. 745-751
Cyclodextrins (CDs) can be envisaged to cure some diseases related to the brain, but the behavior of these compounds toward the blood-brain barrier (BBB) remains largely unexplored to envisage such clinical applications. To fulfill this gap, the toxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e581e8ef447940c1449ff196cfe10b6
https://hal-univ-artois.archives-ouvertes.fr/hal-00537883
https://hal-univ-artois.archives-ouvertes.fr/hal-00537883